the present invention relates to novel 1 - methanamine derivatives , useful as modulators of dopamine neurotransmission , and more specifically asdopaminergic stabilizers . in other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention .